Papers
1
Total Citations
10
H-Index
1
About
Junkang Yu is a leading figure in the advancement of minimally invasive endocrine surgery, with a primary focus on robotic-assisted techniques for thyroid cancer treatment. His most impactful work centers on evaluating the clinical efficacy and oncological safety of the Da Vinci robotic system, particularly through the unilateral axillary approach, compared to traditional open surgery for differentiated thyroid carcinoma. Yu’s landmark 2024 meta-analysis, which has already garnered 10 citations, systematically synthesizes global evidence to address lingering uncertainties about robotic surgery’s technical feasibility and safety. By demonstrating that the robotic approach can achieve comparable oncological outcomes with superior cosmetic results and reduced recovery times, his research has helped shift clinical practice toward less invasive options. This work is especially significant for patients concerned about visible neck scarring. Yu’s contributions are pivotal in defining the evidence base for robotic thyroid surgery, offering surgeons and patients a clear, data-driven rationale for adopting this advanced technology. His ongoing research continues to refine surgical protocols and expand the indications for robotic endocrine procedures.
Research Focus
Key Achievements
Top Papers
- 1